Labcorp is adding to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.  The line…

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer that…

While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry,…

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over last…

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an artificial…

Haemonetics will shell out up to 185 million euros ($216 million) to acquire Vivasure Medical, a Galway, Ireland-based medtech that…

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental…

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping reduce the effects…

After a six-month battle, Edwards Lifesciences has been forced to walk away from its nearly $1 billion takeover attempt of…

Quanterix has a new chief executive and president in Everett Cunningham, but analysts at Leerink see Illumina’s former commercial chief…